SCHEMBL17757978

SCHEMBL17757978

CN1CCC2(CC1)Nc1cc(OCC(N)=O)c(Cl)cc1N=C2NCc1cccc(Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 1/20 0.37
▸ CCNT1 O60563 2/20 0.35
▸ CDK9 P50750 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ THRB P10828 3/20 0.34
▸ ADORA2A P29274 2/20 0.34
▸ ADORA2B P29275 2/20 0.34
▸ AKT2 P31751 1/20 0.34
▸ RPS6KB1 P23443 2/20 0.34
▸ HDAC3 O15379 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CD38 P28907 1/20 0.33
▸ AKT1 P31749 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17757976 0.97 CCNT1 (0.37) HRH4CCNT1CDK9SMN1; SMN2GAA
SCHEMBL21982523 0.88 HTT (0.40) HRH4CCNT1CDK9GAAADORA2A
SCHEMBL17757971 0.86 CCNT1 (0.35) HRH4CCNT1CDK9
SCHEMBL21982511 0.85 HRH4 (0.42) HRH4CCNT1CDK9
SCHEMBL17757969 0.82 CCNT1 (0.37) HRH4CCNT1CDK9
SCHEMBL17757270 0.82 CCNT1 (0.37) HRH4CCNT1CDK9GAATHRB
SCHEMBL17758135 0.82 HRH4 (0.38) HRH4CCNT1CDK9GAAALDH1A1
SCHEMBL17758127 0.82 HRH4 (0.38) HRH4CCNT1CDK9GAAALDH1A1
SCHEMBL21982462 0.80 LMNA (0.35) SMN1; SMN2ALDH1A1RAB9AHPGDMAPT
SCHEMBL17757746 0.79 HRH4 (0.42) HRH4CCNT1CDK9SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2020-05-12 — — US disclosed
WO-2016075137-A1 SPIROPYRAZINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2016-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death AIFM2, BAD, AIFM1 HRH4 3044/4885CCNT1 4252/4885CDK9 3993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback